Japan Mulls Pricing Changes, Generic Sector Review Amid Ongoing Shortages

To stabilize now years-old pharmaceutical supply shortages, especially from generic firms, Japan will review several regulations related to the sector and aspects of its reimbursement pricing scheme. Recently announced economic policies and an official report also refer to potential measures to encourage businesses through financial support and revised pricing premiums.